If you liked this article you might like

Glaxo Stock Slumps as Investors Eye Advair Generics
GlaxoSmithKline Beats Q1 Estimates, Keeps Full Year Targets In Place
Can Anything Dent the Fox News Brand?
These Stocks Are Showing Red Flags -- Here's When to Sell